Influenza vaccine effectiveness in aged individuals: The role played by cell-mediated immunity

European Geriatric Medicine

Volumn 1, Issue 4, 2010, Pages 233-238

  Lang, P O ^a,b   Govind, S ^a   Mitchell, W A ^a   Kenny, N ^a   Lapenna, A ^a   Pitts, D ^a   Aspinall, R ^a  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Cell mediated immunity; Immunosenescence; Older adults; Vaccine effectiveness; Vaccine response

Indexed keywords

INFLUENZA VACCINE; VIRUS HEMAGGLUTININ;

AGED; AGING; CELLULAR IMMUNITY; DRUG EFFICACY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; REVIEW; SENESCENCE; T LYMPHOCYTE;

EID: 77957267972     PISSN: 18787649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurger.2010.07.002     Document Type: Article

References (64)

1. Influenza 2008. Accessed 30th April 2010 at: http://www.who.int/ mediacentre/factsheets/fs211/en/, 2010.
2. World Health Organization Influenza vaccines Wkly Epidemiol Rec 80 2005 279 287
3. A.S. Monto, F. Ansaldi, R. Aspinall, J.E. McElhaney, L.F. Montaño, and K.L. Nichol Influenza control in the 21st century: optimizing protection for older adults Vaccine 27 2009 5043 5053
4. J.E. McElhaney The unmet need in the elderly: designing new influenza vaccines for older adults Vaccine 23 Suppl. 1 2005 S10 S25
5. H.B. Greenberg, and P.A. Piedra Immunization against viral respiratory disease: a review Pediatr Infect Dis J 23 suppl. 11 2004 S254 S261
6. G. Gavazzi, and K.H. Krause Ageing and infection Lancet Infect Dis 2 2002 659 666 (Pubitemid 35265061)
7. N.A. Molinari, I.R. Ortega-Sanchez, M.L. Messonier, W.W. Thompson, P.M. Wortley, and E. Weintraub The annual impact of seasonal influenza in the US: measuring disease burden and costs Vaccine 25 2007 5086 5096 (Pubitemid 46879994)
8. ACIP. Prevention and control of influenza: recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR Recomm Rep 39 RR-7 1990 1 15
9. Note for guidance on harmonization of requirements for influenza vaccines 1997 March 12. CPMP/BWP/214/96 (circular 96-0666): 1-22. Accessed 30 April at http://www.emea.europa.eu/pdfs/human/bwp/021496en.pdf, 2010.
10. K.L. Nichol, J.D. Nordin, D.B. Nelson, J.P. Mullooly, and E. Hak Effectiveness of influenza vaccine in the community-dwelling elderly N Engl J Med 357 2007 1373 1381 (Pubitemid 47535592)
11. G.D. Deans, H.G. Stiver, and J.E. McElhaney Influenza vaccines provide diminished protection but are cost-saving in older adults J Intern Med 267 2010 220 227
12. M.V. Maciosek, L.I. Solberg, A.B. Coffield, N.M. Edwards, and M.J. Goodman Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older Am J Prev Med 31 2006 72 79
13. R. Baxter, J. Lee, and B. Fireman Evidence of bias in studies of influenza vaccine effectiveness in elderly patients J Infect Dis 201 2010 186 189
14. B. Weinberger, D. Herndler-Brandstetter, A. Schwanninger, D. Weiskopf, and B. Grubeck-Loebenstein Biology of immune responses to vaccines in elderly persons Clin Infect Dis 46 2008 1078 1084 (Pubitemid 351589876)
15. S. Sambhara, and J.E. McElhaney Immunosenescence and influenza vaccine efficacy Curr Top Microbiol Immunol 333 2009 413 429
16. T. Fulop, G. Pawelec, S. Castle, and M. Loeb Immunosenescence and vaccination in nursing home Clin Infect Dis 48 2009 443 448
17. R.B. Effros Role of T lymphocyte replicative senescence in vaccine efficacy Vaccine 25 2007 259 604
18. J.E. McElhaney, D. Xie, W.D. Hager, M.B. Barry, Y. Wang, and A. Kleppinger T cell responses are better correlates of vaccine protection in the elderly J Immunol 176 2006 6333 6339
19. Centers for Disease Control Prevention Recommendation of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 53 RR-06 2004 1 40
20. V. Demicheli, D. Rivetti, J.J. Deeks, and T.O. Jeferson Vaccines for preventing influenza in healthy adults The Cochrane Database of Systematic Reviews 3 2004 DOI: 10.1002/14651858.CD001269.pub2. Art No.: CD001269.pub2
21. T.M Goveart, C.T. Thijs, N. Masurel, M.J. Sprenger, G.J. Dinant, and J.A. Knottnerus The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial JAMA 272 1994 1661 1665 (Pubitemid 24359136)
22. D.M. Skowronski, S.A. Tweed, and G. De Serres Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis 197 2008 490 502 (Pubitemid 351321525)
23. B.R. Ruf, K. Colberg, M. Frick, and A. Preusche Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly Infection 32 2004 191 198 (Pubitemid 39070597)
24. J.S. MacKenzie Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly Br Med J 1 1977 200 202
25. N.L. Peters, G. Meiklejohn, and D.W. Jahnigen Antibody response of an elderly population to a supplemental dose of influenza B vaccine J Am Geriatr Soc 36 1988 593 599
26. J.C. Delafuente, J.A. Davis, J.R. Meuleman, and R.A. Jones Influenza vaccination and warfarin anticoagulation: a comparison of subcutaneous and intramuscular routes of administration in elderly men Pharmacotherapy 18 1998 631 636
27. J.A. Buxton, D.M. Skowronski, and H. Ng Influenza revaccination of elderly travellers: antibody response to single influenza vaccination and revaccination at 12 weeks J Infect Dis 184 2001 188 191 (Pubitemid 32614048)
28. L.B. Brydak, M. Machala, J. Mysliwska, A. Mysliwski, and P. Trzonkowski Immune response to influenza vaccination in an elderly population J Clin Immunol 23 2003 214 222 (Pubitemid 36521215)
29. R. Praditsuwan, P. Assantachai, C. Wasi, P. Puthavatana, and U. Kositanont The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community J Med Assoc Thai 88 2005 256 264 (Pubitemid 40813164)
30. S.L. Hui, L.W. Chu, J.S. Peiris, K.H. Chan, D. Chu, and W. Tsui Immune response to influenza vaccination in community-dwelling Chinese elderly persons Vaccine 24 2006 5371 5380 (Pubitemid 43818207)
31. J.E. McElhaney, G.S. Meneilly, K.E. Lechelt, B.L. Beattie, and R.C. Bleackley Antibody response to whole-virus and split-virus influenza vaccines in successful ageing Vaccine 11 1993 1055 1060
32. D.C. Powers, P.J. Hanscome, and P.J.F. Pietrobon In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant Vaccine 13 1995 1330 1335
33. C. Van Hoecke, V. Prikazsky, I. Uto, and C. Menschikowski Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients Gerontology 42 1996 190 198 (Pubitemid 26229374)
34. M. Minutello, F. Senatore, and G. Cecchinelli Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons Vaccine 17 1999 99 104 (Pubitemid 28494106)
35. J. Mysliwska, P. Trzonkowski, E. Szmit, L.B. Brydak, M. Machala, and A. Mysliwski Immunomodulating effect of influenza vaccination in the elderly differing in health status Exp Gerontol 39 2004 1447 1458 (Pubitemid 39410544)
36. K.T. Keylock, T. Lowder, and K.A. Leifheit Higher antibody, but not cell-mediated, responses to vaccination in high physically fit elderly J Appl Physiol 102 2007 1090 1098 (Pubitemid 46377036)
37. J.Q. Feng, U. Gulati, X. Zhang, W.A. Keitel, D.M. Thompson, and J.A. James Antibody quantity versus quality after influenza vaccination Vaccine 27 2009 6358 6362
38. W.E.P. Beyer, A.M. Palache, M. Baljet, and N. Masurel Antibody induction by influenza vaccines in the elderly: a review of the literature Vaccine 7 1989 385 394 (Pubitemid 19252619)
39. J. Legrand, E. Vergu, and A. Flahault Real-time monitoring of the influenza vaccine field effectiveness Vaccine 24 2006 6605 6611 (Pubitemid 46127433)
40. D. Rivetti, T. Jefferson, R. Thomas, M. Rudin, A. Rivetti, and C. Di Pietrantonj Vaccines for preventing influenza in the elderly Cochrane Database Syst Rev 3 2006 CD004876
41. J.E. McElhaney, and R.B. Effros Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol 21 2009 418 424
42. R. Aspinall, D. Pitts, A. Lapenna, and W. Mitchell Immunity in the elderly: the role of the thymus J Comp Path 142 Suppl. 1 2010 S111 S115
43. A. Wikby, B.O. Nilsson, R. Forsey, J. Thompson, J. Strindhall, and S. Löfgren The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning Mech Ageing Dev 127 2006 695 704 (Pubitemid 43949280)
44. A.N. Vallejo CD28 extinction in human T-cells: altered functions and the program of T-cell senescence Immunol Rev 205 2005 158 169
45. T. Hünig, F. Lücher, K. Elfein, T. Gogishvili, M. Frölich, and R. Guler CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation Med Microbiol Immunol 2010 Apr 14 Epub ahead of print
46. L.E.S. Haynes The effect of age on the cognate function of CD4+ T cells Immunol Rev 205 2005 220 228
47. D. Weiskopf, D. Weinberger, and B. Grubeck-Loebenstein The aging of the immune system Transplant International 22 2009 1041 1050
48. A. Lang, J.D. Brien, I. Messaoudi, and J. Nikolich-Zugich Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication J Immunol 180 2008 4848 4857
49. G. Pawelec, E. Derhovanessian, A. Larbi, J. Strindhall, and A. Wikby Cytomegalovirus and human immunosenescence Rev Med Virol 19 2009 47 56
50. C. Franceschi, M. Capri, D. Monti, S. Giunta, F. Olivieri, and F. Sevini Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans Mech Ageing Dev 128 2007 92 105 (Pubitemid 46073065)
51. J. Strindhall, B.O. Nilsson, S. lofgren, Ernerudh, G. Pawelec, and B. Johansson No immune risk profile among individuals who reach 100 years of age findings from the Swedish NONA immune longitudinal study Exp Gerontol 42 2007 753 761 (Pubitemid 47058867)
52. H.C. Hsu, D.K. Scott, P. Zhang, J. Zhou, P. Yang, and Q. Wu CD8 T cell immune phenotype of successful aging Mech Ageing Dev 127 2006 231 239 (Pubitemid 43214495)
53. J.C. Chen, F.C. Lim, Q. Wu, Q.W. Douek, D.K. Scott, and E. Ravussin Maintenance of naïve CD8 T-cells in nonagerians by leptin. IGFBP3 and T3 Mech Ageing Dev 131 2010 29 37
54. X. Yu, T. Tsibane, P.A. McGraw, F.S. House, C.J. Keefer, and M.D. Hicar Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors Nature 455 2008 532 536
55. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010;375:1100-8.
56. Gijzen K, Liu WM, Visontai I, Oftung F, van der Werf S, Korsvold GE, et al. Standardization and validation of assays determining cellular immune responses against influenza. Vaccine 2010;28:3416-22.
57. S.A. Plotkin Vaccines: correlates of vaccine-induced immunity Clin Infect Dis 47 2008 401 409
58. N. Jia, C. Li, Y.X. Liu, J.H. Richardus, D. Feng, and H. Yang Lower cellular immune responses to influenza A (H3N2) in the elderly J Med Virol 81 2009 1471 1476
59. Y. Dend, Y. Jing, A.E. Campbell, and S. Gravenstein Age-related impaired type 1 T cell response to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly J Immunol 172 2004 3437 3446 (Pubitemid 38337923)
60. G. Almanzar, D. Herndler-Brandstetter, S.V. Chaparro, B. Jenewein, M. Keller, and B. Grubeck-Loebenstein Immunodominant peptides from conserved influenza proteins: a tool for more efficient vaccination in the elderly? Wien Med Wochenschr 157 2007 116 121 (Pubitemid 46623294)
61. R.B. Effros Telomerase induction in T cells: a cure for aging and disease? Exp Gerontol 42 2007 416 420
62. S.R. Fauce, B.D. Jamesion, A.C. Chin, R.T. Mitsuyasu, S.T. Parish, and H.L. Ng Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes J Immunol 181 2008 7400 7406
63. P.R. Blank, M. Schwenkglenks, and T.D. Szucs Vaccination coverage rates in eleven European countries during two consecutive influenza seasons J Infect Dis 58 2009 446 458
64. K. Goodwin, C. Viboud, and L. Simonsen Antibody response to influenza vaccine in the elderly: a quantitative review Vaccine 24 2006 6808 6811 (Pubitemid 43202262)